INSIG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.09230000000515E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.236620E-04 |
Normal-vs-Stage2 |
4.735800E-02 |
Normal-vs-Stage3 |
2.37410002768002E-09 |
Normal-vs-Stage4 |
6.74440000514309E-08 |
Stage1-vs-Stage2 |
4.863400E-01 |
Stage1-vs-Stage3 |
4.200600E-03 |
Stage1-vs-Stage4 |
4.856000E-02 |
Stage2-vs-Stage3 |
3.904300E-02 |
Stage2-vs-Stage4 |
8.215900E-02 |
Stage3-vs-Stage4 |
5.142200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.40590000003083E-06 |
Normal-vs-AfricanAmerican |
1.168140E-04 |
Normal-vs-Asian |
5.980500E-02 |
Caucasian-vs-AfricanAmerican |
6.332400E-01 |
Caucasian-vs-Asian |
8.666200E-01 |
AfricanAmerican-vs-Asian |
9.822600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.82040000000461E-05 |
Normal-vs-Female |
2.07709999977546E-07 |
Male-vs-Female |
2.136600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.961990E-02 |
Normal-vs-Age(41-60Yrs) |
4.18440000000686E-05 |
Normal-vs-Age(61-80Yrs) |
9.33889999998883E-07 |
Normal-vs-Age(81-100Yrs) |
5.836400E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.394400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.559400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.567000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.326000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.542000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.925200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.775100E-04 |
Normal-vs-Grade 2 |
4.36619999999444E-06 |
Normal-vs-Grade 3 |
2.38220000392531E-08 |
Normal-vs-Grade 4 |
1.26020000001947E-06 |
Grade 1-vs-Grade 2 |
9.119400E-01 |
Grade 1-vs-Grade 3 |
3.129600E-01 |
Grade 1-vs-Grade 4 |
4.420600E-01 |
Grade 2-vs-Grade 3 |
1.014160E-01 |
Grade 2-vs-Grade 4 |
2.376400E-01 |
Grade 3-vs-Grade 4 |
8.128600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.69729999131152E-09 |
Normal-vs-ccB subtype |
2.407900E-02 |
ccA subtype-vs-ccB subtype |
4.297600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.72149999495042E-08 |
Normal-vs-N1 |
1.36769999992126E-07 |
N0-vs-N1 |
2.246400E-01 |
|
|